Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Dec. 21, 2021

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

Dec. 21, 2021

Sosei and Twist collaborate to discover therapeutic antibodies against GPCR targets

Dec. 17, 2021

iECURE and Penn to develop next-generation LNPs for liver gene editing applications

Dec. 17, 2021

BridGene and Peter MacCallum Cancer Centre enter research collaboration for ovarian cancer

Dec. 16, 2021

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

Dec. 14, 2021

3SBio's Sunshine Guojian subsidiary to develop Numab's NM-28 in Greater China area

Dec. 14, 2021

Lilly and Foghorn collaborate on Foghorn's selective BRM program and additional programs

Dec. 13, 2021

Tonix and Columbia University to explore rTFF2-based therapy for gastric and colorectal cancers

Dec. 13, 2021

Biosion licenses BSI-04702 to OBI Pharma to develop next-generation biologics

Dec. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...